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My name is Sarah Bishop and I am a pursuing a Bachelor of Science degree in both 
chemistry and biology at Ouachita Baptist University. Part of my degree is obtaining research 
hours for both chemistry and biology. In the summer of2013, I participated in research at the 
University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Department of 
Pharmaceutical Sciences under the INBRE Summer Research Fellowship. As a result of my 
research experience I produced this thesis is addressed to future and current science students at 
OBU and science students in general. This thesis addresses how my idea of research has 
changed before and after this experience and how I have changed as a student and as a person. 
Please enjoy. 
Pre-research ideas: 
I thought I would be wearing a lab coat and goggles, sitting at a clean white lab bench 
and be in a chemistry setting with bunsen burners. I thought I would report to my mentor the 
results of the tests I ran and then go back to work. I thought I would have privacy and be a 
professional ... a chemist. I know it sounds as if I viewed myself as a very capable woman. 
After all, I did just come out of the class Experimental Techniques, where we used practically 
every instrument available in the chemistry department to analyze compounds we synthesized. I 
thought I knew everything about working in a lab. And oh, how I was wrong. Just because I 
would make A's on my paper and knew how to work the instruments at OBU (well, at least I 
thought I knew how to run the instruments) did not mean I knew how to work the instruments at 
UAMS, or would even be allowed to. Something I learned at UAMS was that I would actually 
have to understand, truly understand, and truly grasp, the concept of my research, not be able to 
just put words on a paper and get fluorescence results back, but truly understand what the 
fluorescence meant. 
When asked a question, there were no other students I could hide behind. No more "sit 
quietly, head down and wait until someone else says something," because I didn't want to look 
like a fool. No. It was me and Dr. Liu. It was me answering questions, or at least giving an 
answer, and hoping it was right. Me feeling dumb at times for not remembering anatomy and for 
feeling like I was embarrassing my school and professors for passing me in the class when I 
could not remember the material now. Me feeling embarrassed and ashamed telling Dr. Liu I 
wanted to become a pharmacist when I could not remember some important equilibriums in the 
blood stream. I felt like crying some times when asked a math question for dilutions and I felt it 
was an eternity before I answered. Where was my pen and paper and, for goodness sakes, my 
calculator?! No, Dr. Liu made me give an answer on the spot and made me toughen my skin on 
the spot. 
Please don't get me wrong, Dr. Liu was a very kind and patient man. He encouraged 
questions and understood I could not know everything. He only had one rule: a student is not to 
be blamed, until they are taught the lesson. Once they are told the correct answer, it is then their 
responsibility to remember it. 
The INBRE Fellowship was a 10-week program which consisted of research, a final 
paper, and a presentation. Dr. Liu and I spent the first two days discussing the background in the 
research and how to fit a project into ten weeks. I know that may sound like some time, but ten 
weeks was broken down into one week to plan, six weeks to run the experiment and collect data, 
one week to prepare a powerpoint for presentation, one week to practice and present, and then 
the final week to clean up in lab. Practically, only six weeks for lab work. 
As time went on, I began to grasp the concepts. I began to be not as afraid to give the 
answers to the questions, and started to get answers right! I started to form a trusting relationship 
with my mentor. I felt more on his level, not professionally or academically, but where I could 
have a conversation with him about the research instead of being told about the research. 
For the most of the lab time, Dr. Liu would be watching over my shoulder. I would be 
able to do most of the work myself such as changing the water for the mice, cleaning their cages 
and making solutions, but he would do the ultrasound and termination of the mice at the end. I 
was never alone and at first felt insulted, because I thought he assumed I couldn't do anything, 
but that was just rude of me. It was his lab and he wanted to make sure I didn't waste any of his 
materials. He wanted to ensure that the solutions were properly made and to be honest, I am glad 
he was there, because I would probably have messed up ifhe wasn't. Dr. Liu also showed me 
some tricks to help better my lab technique. 
Over the six weeks of research, I ran tests, collected data and made conclusions. The 
following describes my lab procedures and contains the results of the experiments. Preceding 
this paragraph was what I thought of research before I started work. Following my research, my 
views have changed and my appreciation has greatly increased of research and researchers. 
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Abstract 
The bark of Terminalia arjuna (TA), a tropical tree, has been used in Ayurvedic 
medicine for treatment of cardiovascular disease. TA bark is known to contain various 
antioxidants, and recently it has been suggested to enhance function of the normal heart as 
an over-the-counter supplement in the USA. The mechanism underlying cardiac actions of 
TA bark are unknown. Doxorubicin (DOX), a commonly-used anticancer drug, is known to 
cause cardiotoxicity, a major concern in chemotherapy. The aim of this study is to 
investigate whether aqueous extracts of TA bark (TAaq) protect the heart from DOX 
treatment by counteracting the oxidative stress caused by DOX. H9c2 cells, a cell line 
derived from the rat heart, were used for the in vitro study to examine cellular mechanis(s) 
of actions of TAaq. Echocardiography was used to monitor cardiac function of mice with 
and without co-treatment of DOX and TAaq· Our results showed that treatments of H9c2 
cells with DOX (1 J.lM) for 24 hr caused an increase in superoxide production and damage 
to the growth network which were attenuated by co-treatment with TAaq (100 J.lg/ml). Our 
in vivo data showed that TAaq (50-100 f.1g/ml in drinking water) prevented the decrease in 
left ventricle function caused by multiple weekly treatments with DOX. These preliminary 
data suggest that TAaq protects the heart in part from oxidative stress caused by DOX. 
Introduction 
Doxorubicin (DOX), a commonly-used anticancer drug, is known to cause cardiotoxicity 
likely via increased oxidative stress of cardiac myocytes (1 ). The cardiotoxicity of DOX is a 
major concern in cancer chemotherapy. The bark of Terminalia arjuna (TA), a tropical tree, has 
been used in Ayurvedic medicine for treatment of cardiovascular disease for centuries. TA bark is 
known to contain active organic constituents such as tannins, triterpenoid saponins, flavonoids, 
gallic acid, ellagic acid, oligomeric proanthocyanidins, and phytosterols, and recently it has been 
suggested to enhance function of the normal heart as an over-the counter supplement in the USA. 
However, the mechanism underlying cardiac actions of TA bark are unknown. The aim of this 
study is to investigate whether aqueous extracts of TA bark (TAaq) protect the heart from DOX 
treatment by counteracting the oxidative stress caused by DOX. 
Experimental Procedures 
TAaq bark preparations 
The aqueous extracts of TA bark were prepared as described previously (2). Briefly, 
1.005g of pulverized crude TA bark was added to 50 mL of boiling milli-Q water and continued 
to boil for 15-20 minutes. After centrifugation at 6000 x g for 2 minutes, the supernatant 
(decoction) was collected and filtered through a 0.22 ~ filter. The concentration and percent 
yield for the TAaq stock solution was 4.5 mg/ml and 20%, respectively. 
Growth medium 
H9c2 cells (American Type Culture Collection® CRL-1446™), a commonly used cell 
model derived from rat heart, were cultured in Dulbecco's Modified Eagle's Medium (DMEM) 
following ATCC instructions. Briefly, cells were thawed and maintained in high glucose DMEM 
medium supplemented with 10% FBS growth medium in a T-25 culture flask incubated at 37°C. 
After growing to approximately 70% confluence, cells were distributed to 24-well plates for 
study. 
Fluorescence microscopy 
Two fluorescent dyes were used to detect the oxidative stress of H9c2 cells; one 
superoxide-sensitive dihydroethidin (DHE) and mitochondria-sensitive MitoTracker®, both of 
whose oxidized forms emit fluorescence detected at 580 nm (excitation at 535 nm). H9c2 cells 
were treated with TAaq (100 J..lg/rnL) 20-30 min before DOX (1 J..tM) treatment and maintained in 
a 5% COz incubator at 37°C for 2-24 hours. At 30-45 min before the termination ofDOX 
treatments cells were incubated with DHE (3 J..lM) or MitoTracker® (0.1 J..lM) in the incubator at 
3 7°C. At the end of experiments, dyes were washed off with Hepes-buffered salt solution. The 
fluorescence images ofDHE and MitoTracker were acquired withAxioVision software using the 
same exposure duration to yield sub-maximal intensity at the same magnification within each 
individual experiment, and analyzed using NIH ImageJ. 
Daily drinking water and DOX treatment 
Four C57/BL6 mice were used for the in vivo experiment. Two of four C57/BL6 mice 
received drinking water containing TAaq (50 or 100 J..lg/mL) for 4 days before DOX injection. 
Water intake of each mouse was measured and recorded daily. Water was daily replaced with 
freshly-made TA bark drinking water. One of the two C57/BL6 mice receiving drinking water 
containing TA and one of the two C57/BL6 mice receiving drinking water not containing TAaq 
received a weekly injection ofDOX (10 mg/kg body weight, i.p.) for two weeks. The other two 
mice, one of which received drinking water containing TAaq and one receiving drinking water not 
containing TAaq, received a weekly injection of the same volume of saline. 
Echocardiography 
Echocardiograms were obtained using a Vevo® 2100 high-resolution imaging system 
(VisualSonics) specifically for the analysis of small animals. Briefly, the mouse was weighed 
and anesthetized with isoflurane at 3% at 1 liter per minute (lpm) medical-grade air. Once the 
mouse was unconscious, the mouse was quickly transferred and taped to a heated platform in a 
dorsal recumbent position. The isoflurane was then reduced to 1%. Vital signs (heart rate, 
respiration rate and body temperature) were monitored throughout the imaging. 
The hair of the chest was removed using a chemical hair remover (Nair). Prewarmed ultrasound 
gel (Aquasonic 1 00) was spread over the clean chest. A MS-550D probe was used to acquire 
ultrasound images of the heart. The ultrasound examination for each mouse took less than 
1 hour. After the examination, the mouse regained consciousness and was returned to its cage. 
Echocardiography was performed weekly to assess the left ventricular function before, during, 
and 2 weeks after 2-week treatments with DOX. 
Histological examination 
After termination of the mice, the heart was removed from the body and flushed through 
the aorta with control HTBSS solution followed by 10% neutral buffered formalin. After being 
blotted dry, the heart was weighed to determine the ratio of heart weight to body weight. The 
heart of each mouse was then returned to the buffered formalin solution for 24 hours before 
being embedded in paraffin. Each heart was cut into sections of 5-f..lm thickness which were 
mounted on glass microscope slides. Histological analysis of the sections of each heart was 
performed after a Gomori Trichome stain (performed by pathology core facility). 
Results and Discussion 
Attenuation of DOX-induced superoxide production and cell damages by TAaq 
Oxidative stress of H9c2 cells was assessed using superoxide-sensitive DHE staining of 
cells treated with DOX and co-treated with TAaq for 24 hours. Figure 1 shows after 24 hours, 
DOX ( 1 f..l.M) enhanced superoxide production (Figure 1 C) compared with the control (Figure 
1A) and TAaq alone (Figure 1B). DOX also reduced cell growth and connection and reduced the 
cell number (Figure 1 C). Cotreatment of DOX with TAaq significantly reduced the production of 
superoxide and cell damage (Figure 1 D). The quantitative analysis of relative superoxide 
production induced by DOX and inhibition by TAaq is shown in Figure 2. 
~ 
Figure 1. Superoxide production was measured by DHE fluorescence in H9c2 cells treated with or 
without DOX and co-treatment with or without TAaq for 24 hours. 
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Figure 4. Mitochondrial oxidative stress detected by MitoTracker® in cells treated with DOX (1 J.LM) and/or co-
treated with TAaq (LO mg/ml) + DOX (L J.LM) 
\(' 1 . 
DOX is known to induce oxidative stress in heart cells, a primary mechanism underlying 
its side effect of cardiotoxicity. This study used H9c2, a commonly-used cell model derived 
from embryonic rat heart to investigate the 
protective effect of TAaq on DOX-induced 
cardiotoxicity. First, our results demonstrated a 
DOX-induced increase in superoxide production 
and cell damage in H9c2 cells, consistent with 
those described in the literature. Second, our 
results showed that the increased oxidative stress 
was specifically localized in the mitochondria of 
H9c2 cells, suggesting that DOX causes damage to 
mitochondria in these cells. Third, our data showed 
that TAaq, a known cardiotonic, reduced DOX-
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DOX-induced decline in left ventricu/Jzr (LV) function of the mouse heart 
Weekly echocardiography enabled 
the assessment of LV function before, 
during, and after treatment of mice with 
DOX. In this study, two groups of mice 
were given drinking water containing 
freshly-made TAaq four days before DOX 
treatments. Figure 6 shows representative 
echocardiograms of the heart in an 
untreated and DOX-treated mouse, 
Ratio (4"' week to· the bas.~lioe) 
Con1rol TA DOX. TA+DOX 
l VID;d 0 .94 1.00 • ~0 0.85 
LVIO;s 0.8.9 1.08 .50 0.70 
Strok{t VoltJmo 1.05 0.93 0.74 0.98 
Ejection Fraction 1.25 OJlO 0.79 1.45 
Ce.rtfiec OutJXJC 1.04 0.93 0.74 0.89 
Table 1. Relative change in parameters of cardiac function in 
TAaq, DOX and TAaq+DOX mice. LVID: LV internal dimension 
respectively. The measured parameters are shown in Table 1 and Figure 7. The cardiac function 
of individual hearts at the 4th week was compared to that before pharmacological intervention (or 
the baseline). During the period of 4 weeks, cardiac function did not significantly change in the 
control and TAaq-treated mice. In contrast, there was more than a 20% decline in cardiac function 
of the DOX-treated heart 2 weeks after termination ofDOX injection. The DOX-induced decline 
in cardiac function was not observed in the mouse treated with TAaq prior to DOX injections. 
I 
Figure 7 shows that the cardiac function in control and TAaq-treated hearts remained 
relatively constant during this 4-week experiment. One week after the 1st injection ofDOX, the 
ejection fraction of the heart was transiently increased, possibly due to adaptive response of 
cardiac function to DOX. However, the ejection fraction declined more than 20% 2 weeks after 
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Figure 7. Chronological monitor of function of the mouse heart in these 4 groups 
This result was consistent with the clinical observation that cardiotoxicity is often observed a 
certain period of time after termination of chemotherapy (1,3). In summary, the 
echocardiographic (in vivo) data are consistent with the in vitro data, i.e. , TA aq prevented the 
decline in cardiac function induced by DOX treatment. 
Conclusion 
Our data suggest thar L4aq exerts protective and therapeutic effects on DOX-induced 
cardiotoxicity, likely resulting in part from its capability to reduce the mitochondrial oxidative 
stress caused by DO X. Thus TAaq is of potential value in the clinic for cancer patients receiving 
chemotherapy. Future studies will investigate detailed cellular mechanism(s) underlying the 
cardiac protective action of TAaq and identify correspondent active components in TAaq. 
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Post-research ideas: 
What I considered, at the beginning of my research, annoying and added pressure with 
Dr. Liu standing behind me, became enjoyable and needed. When I was alone in the lab, there 
were times it was hard not to mess up and at times it could be lonely. At other times, I became 
more comfortable in the lab and enjoyed the relaxation. 
I thought people did research for their own personal gain. I know the reason for doing 
research is to help others and to find a cure, but with the great discoveries come great fame and 
great fortune ... Nobel Prize fortune. I mean, this is your career after all. You go through years 
of school, so why don't you want recognition for your intellectual abilities and break-through 
ideas? I thought you would want recognition, and I was right to a point. It wasn't so much 
wanting to be published for personal gain, but for professional gain-professional gain to be able 
to earn more grants, maintain and expand your lab space, hire lab technicians, and maintain your 
job. I did not realize there are many research institutions with the motto "publish or perish." 
Researchers need grants to provide the funding to buy the expensive antibodies, the expensive 
chemicals, and pay for the expensive instruments to be used. Researchers need to be published 
to show their research had meaningful results and to prove to organizations which provide grants 
that the money they give will be well spent and will be furthering research. 
My mentor, Dr. Liu, does research because it interests him and he wants to find a cure to 
a problem facing patients. He wants to help people. While I am sure there are some exceptions, 
as there seem to be in every situation in life, the people at UAMS all seemed to have heart, drive, 
charisma, a purpose and goal for their work. Their research is their baby. 
One day in lab, I was talking to Dr. Liu and we came to talk about one of his friends who 
just found out she had breast cancer. One of the downfalls about being in science and cancer 
research is that you know the statistics, the downsides of chemotherapy, and the long term effects 
of treatment. Our project was examining how to lower the cardiotoxic effects of doxorubicin, a 
commonly used anticancer drug. We were examining how the aqueous extracts of Terminalia 
arjuna bark can protect the heart from doxorubicin-induced oxidative stress, which would cause 
heart problems or heart failure 5-15 years after treatment with doxorubicin. 
Dr. Liu knows his friend could be treated with doxorubicin and knows the resulting 
effects doxorubicin would have on her heart. One cannot be ignorant. However, there is a bright 
side. Dr. Liu is researching a cure for this. Adding the aqueous extracts of the Terminalia arjuna 
bark could prevent or delay the damage the doxorubicin causes on the heart. He is researching 
something that could prevent people from having as many heart conditions due to treatment of 
doxorubicin. His research could helping limit the worry cancer patients have about the side 
effects the chemotherapy has on their heart and allow them to enjoy life. 
The answer can lie in a few tests. It could be a simple fix: just consume TAaq and DOX at 
the same time during chemotherapy. No worries, no problems, no fear of the future. A solution 
was there. I was looking at it, working with it. Why was this not on the market? Why was 
funding hard to get for this? Why? The answers facing so many problems with current 
medicine, cancer and cardiovascular issues was right there. It is amazing how he could come up 
with this hypothesis, how he could put these pieces together. 
So, what was a main reason he had trouble finding funding? He didn't know what the 
active compounds were in the TAaq. Before funding, organizations want to know what is in TAaq. 
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funding hard to get for this? Why? The answers facing so many problems with current 
medicine, cancer and cardiovascular issues was right there. It is amazing how he could come up 
with this hypothesis, how he could put these pieces together. 
So, what was a main reason he had trouble finding funding? He didn't know what the 
active compounds were in the TAaq. Before funding, organizations want to know what is in TAaq. 
Dr. Liu said he would need funding in order to be able to carry out the tests. He needed someone 
to have faith in him that even though he didn't know what the TAaq was composed of, the 
investment of money into tllls research could lead to promising results to the investigation of 
TAaq and its interactions with DOX. However, the money from funding comes from government 
dollars, tax dollars, your dollars. Therefore, just "giving away" the money on a leap of faith is 
not encouraged. Furthermore, most analytical techniques and compounds are organic- our 
solution is an aqueous solution. Organic and aqueous solutions separate out from one another 
and many solvents used when analyzing organic compounds cannot be used to analyze aqueous 
compounds. This was the problem facing Dr. Liu. 
When I began this fellowship, I thought I understood research and I thought I gave 
research its proper respect. I was wrong. My view of research has expanded and my 
appreciation has elevated. We are surrounded by hundreds of people who stay in a lab half the 
size of many classrooms, sometimes crammed with supplies and instruments and run a single test 
multiple times in order to make sure results are conclusive. Sometimes the results of the tests are 
not what one expected to see; sometimes you think you might have found a solution, but the tests 
say you didn't so you have to try again. 
Researchers do not give up. Researchers read countless scientific journals, articles and 
papers which other researchers have written to try to use the information they found and combine 
with their own to find an answer or make a discovery. Researchers are the ultimate treasure 
hunters. The treasure they seek is a solution to the problem, whether that is fixing the side 
effects of certain cancers, turning receptors back on to prevent cancer or whatever the solution 
may be. They obtain their clues by reading, testing and taking chances. There is so much not 
known in science. There are clues not found yet. Researchers make the connections no one has 
made yet. 
My mentor has been working on our project in bits and pieces for over seven years. 
When he participates in undergraduate fellowship research he has the funds to work on the 
project. It takes time and motivation to not give up. Research also takes creativity. Some 
people think it is easy to classify someone as an artsy or scientific, type A or type B personality, 
cluttered or organized; however, a scientist needs both. Scientists must be organized and 
meticulous, but they also have to be creative. Research is not about reproducing someone else's 
work. It is about taking someone else's findings, combining them with your current knowledge 
and creating a unique experiment to demonstrate your ideas or hypothesis of what may happen. 
Researchers also have to be aware of their audience, as in the organizations which fund the 
projects and give the grants. Researchers have to make sure they are researching something 
which will be of interest to the organizations and appeal to them, because researchers need their 
projects to be selected in order to have money to support their research. 
I conducted research the summer of 2013 at DAMS in Dr. Liu 's lab. In the fall of 2014, I 
will be attending UAMS College of Pharmacy. My whole thesis has been fueled by my respect 
for research and appreciation for my experience, but I myself am not pursuing a career in 
research. Please do not think in any way that my thesis is hypocritical or insincere because I am 
not pursuing that career path myself. That summer has shown me a new insight into research, 
allowed me to make new friends, expand my network, go on field trips to places I would not 
have been able to attend before, present at conferences, and travel. I am thankful. I am honored 
and truly enjoy presenting my work and get excited to share the good news of my results. I 
would consider research as a summer job because research can be relaxing at times when the 
work and tests conducted become a habit; however, they can also become very repetitive and I 
desire some variety in my future career. 
I am still in contact with Dr. Liu and send him updates in relation to pharmacy school and 
presentations. I will see Dr. Liu again- many times, actually. He will be one of my pharmacy 
teachers at DAMS. I may not learn anything about the tree bark of Terminalia arjuna in his 
class, but I know I will be learning. That's what life is: we learn, we grow, we make mistakes, 
we want redos, we practice learning, we practice speaking, we practice new skills and we will 
eventually make progress. So, no matter what specific area of pharmacy, science or life I find 
myself in, as long as I keep moving forward and keep learning I am making progress and making 
a difference. That is what research taught to me to do with my life: make a difference. If we can 
each do that with our own lives, we will each be a success. 
